Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,931,642,052
+$1,344,561,417 QoQ
Shares Held
44,721,167
-3.5% QoQ
Ownership
1.86%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 45.70794630649956.ToString("F0")%
Shared 0.ToString("F0")%
None 54.29205369350044.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. JNJ ranks #2 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,198,554 | $1,770,892,290 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,931,642,052 | 44,721,167 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,587,080,635 | 46,325,589 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $8,943,115,683 | 48,231,667 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,176,938,426 | 46,984,867 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $7,633,729,454 | 46,030,689 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,350,183,203 | 43,909,440 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,318,974,616 | 45,162,129 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $6,148,844,351 | 42,069,269 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $6,730,975,474 | 42,549,943 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $6,529,706,729 | 41,659,479 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,423,924,475 | 41,245,101 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $6,897,089,120 | 41,669,219 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,200,545,600 | 40,003,520 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,458,961,626 | 42,224,521 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,159,237,056 | 37,703,459 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,730,471,106 | 37,916,011 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $4,610,229,930 | 26,012,695 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $4,405,708,548 | 25,753,835 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,020,707,388 | 24,896,021 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,129,495,401 | 25,066,744 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,994,682,549 | 24,305,948 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,794,593,583 | 24,111,028 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,345,745,248 | 22,472,765 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,028,999,889 | 21,538,789 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,727,691,904 | 20,801,433 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||